3rd Quarter - Report

PODESTA GROUP, INC. for CUBIST PHARMACEUTICALS INC

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Medical research. Antibiotic resistance issues. H.R. 2182 / S. 1734, Generating Antibiotic Incentives Now Act of 2011. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 3187, Food and Drug Administration Safety and Innovation Act. S. 3295, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2013. H. J. Res. 117, Continuing Appropriations Resolution.

LobbyistCovered position, as disclosed
SHARON COHEN —
THOMAS B SPARKMAN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 3295 (112th), H.R. 2182 (112th), H.R. 5651 (112th), S. 1734 (112th), S. 3187 (112th), H.J.Res. 117 (112th)

Medicare/Medicaid MMM

Medicare home infusion and reimbursement issues. 340B drug pricing program issues, including program expansion. H.R. 2195 / S. 1203, Medicare Home Infusion Therapy Coverage Act of 2011. H. Con. Res 112, Establishing the budget for the US Government for FY 2013 (Medicare-related provisions). Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation). H.R. 5194, Rural Hospital and Provider Equity and 340B Improvement Act of 2012. H.R. 5624, Rural Hospital and Provider Equity and 340B Improvement Act of 2012.

LobbyistCovered position, as disclosed
SHARON COHEN —
THOMAS B SPARKMAN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 2195 (112th), H.R. 5624 (112th), H.Con.Res. 112 (112th), S. 1203 (112th), H.R. 5194 (112th)

Budget/Appropriations BUD

H. Con. Res 112, Establishing the budget for the US Government for FY 2013 (Medicare-related provisions). H.R. 5973 / S. 2375, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013. H. J. Res. 117, Continuing Appropriations Resolution, 2013.

LobbyistCovered position, as disclosed
SHARON COHEN —
THOMAS B SPARKMAN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.J.Res. 117 (112th), H.R. 5973 (112th), H.Con.Res. 112 (112th), S. 2375 (112th)

Pharmacy PHA

Antibiotic resistance issues. Pay-for-delay proposals and generic issues. H.R. 2182 / S. 1734, Generating Antibiotic Incentives Now Act of 2011. Prescription Drug User Fee Act reauthorization. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 2516, Food and Drug Administration Safety and Innnovation Act. S. 3187, Food and Drug Administration Safety and Innovation Act. S. 2292, Patients' FDA Act. S. 2289, Better Pharmaceuticals and Devices for Children Act of 2012. H.R. 6433, FDA User Fee Corrections Act of 2012.

LobbyistCovered position, as disclosed
SHARON COHEN —
THOMAS B SPARKMAN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 1734 (112th), H.R. 5651 (112th), H.R. 6433 (112th), H.R. 2182 (112th), S. 2516 (112th), S. 3187 (112th), S. 2289 (112th), S. 2292 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.